Announcement: Aurelia Bioscience has been acquired by Charnwood Molecular.

Share this

Charnwood Molecular's Chief Commercial Officer, Mark Chadwick is attending the event which promises to help to shape the future of biotechnology and celebrate the many scientific discoveries.

The theme is very much ‘LIMITLESS’ possibilities to explore alongside thousands of global biotechnology and pharma leaders. The programme promises to dive into topics such as business development, healthcare innovations, and the future of biotechnology.

If you have a drug discovery project you would like to talk about with Mark, you can use the event partnering system or connect with him on LinkedIn.